| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4feda2a82a4adcd92a7619df2248333 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 |
| filingDate |
1999-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfca8ecf3fd400c820d53b8b0c724b91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c43a773ec1ef5a38edb1e5c0156d10f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba211fe43109fbc8fb031e0ed8a9a670 |
| publicationDate |
2001-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1080723-A1 |
| titleOfInvention |
INHIBITION OF IgA PRODUCTION |
| abstract |
The production of IgA is selectively inhibited by orally administering 15-deoxyspergualin or pharmacologically acceptable salts thereof, thus preventing and treating IgA-associated immunological diseases such as IgA nephropathy. |
| priorityDate |
1998-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |